TABLE 1

Clinical and demographic characteristics of the study population (study population and population included in the multivariable model)

Baseline analysisMultivariable model
Male23 096/43 786 (52.75)8120/15 582 (52.11)
Socioeconomic status of country
 High-income group29 918/43 786 (68.33)9781/15 582 (62.77)
 Middle-income group10 042/43 786 (22.93)4336/15 582 (27.83)
 Low-income group3826/43 786 (8.74)1465/15 582 (9.40)
Age at diagnosis, months42 02315 582
4.86±10.493.0±7.06
0.0–86.00.0–49.0
Age at diagnosis
 0 years23 744/42 023 (56.50)9731/15 582 (62.45)
 1–10 years12 160/42 023 (28.94)4400/15 582 (28.24)
 11–18 years2413/42 023 (5.74)732/15 582 (4.70)
 >18 years3706/42 023 (8.82)719/15 582 (4.61)
BMI (first year in the ECFSPR)38 533NA
−0.43±1.18NA
−1.07–0.36NA
Neonatal screening
 Not performed28 476/35 460 (80.30)11 074/15 582 (71.07)
 Performed, result positive4668/35 460 (13.16)2987/15 582 (19.17)
 Performed, result negative242/35 460 (0.68)175/15 582 (1.12)
 Performed, result unknown2074/35 460 (5.85)1346/15 582 (8.64)
Meconium ileus at birth
 No35 548/40816 (87.09)13 926/15 582 (89.37)
 Yes, operated2791/40 816 (6.84)893/15 582 (5.73)
 Yes, not operated869/40 816 (2.13)306/15 582 (1.96)
 Yes, don't know if operated1608/40 816 (3.94)457/15 582 (2.93)
Chloride value, mmol·L−1 (sweat test)22 74715 582
93.95±25.5395.9±24.58
97.00 (80.0–110.0)99.0 (83.0–110.0)
1.0–170.01.0–170.0
Mutation
 Both class I/II9053/43 786 (20.68)3830/15 582 (24.58)
 Both F508del17 133/43 786 (39.13)6311/15 582 (40.50)
 At least one of class III1393/43 786 (3.18)562/15 582 (3.61)
 At least one of class IV3006/43 786 (6.87)1152/15 582 (7.39)
 At least one of class V2501/43 786 (5.71)987/15 582 (6.33)
 One of class I/II, other mutation in class unknown or both mutations unknown or genetic test not performed10 520/43 786 (24.03)2740/15 582 (17.58)

Data are presented as number of subjects with specific characteristics/total number of subjects with information on the variable (%), n, mean±sd, range or median (interquartile range). BMI: body mass index; ECFSPR: European Cystic Fibrosis Society patient registry; NA: not applicable.